CDKN2A and squamous cell carcinoma: In parallel, genomic profiling has revealed recurrent mutations in TP53, HGF, epidermal growth factor receptor, TERT, and CDKN2A, suggesting that OSSN shares common oncogenic pathways with other squamous cell carcinomas.